Skip to main content

and
  1. No Access

    Article

    Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer

    CD133/ prominin 1 is a cancer stem cell marker associated with cancer progression and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) remains obscure. The current stu...

    Chitra Joseph, Maariya Arshad, Sasagu Kurozomi in Breast Cancer Research and Treatment (2019)